Clinical trial
A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-Coil Deep Transcranial Magnetic Stimulation (TMS) in Conjunction With Mood Stabilizers in Subjects With Bipolar Depression
NCT01566591 is registered in ClinicalTrials.gov with Brainsway as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-Coil Deep Transcranial Magnetic Stimulation (TMS) in Conjunction With Mood Stabilizers in Subjects With Bipolar Depression
- Lead sponsor
- Brainsway
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 31, 2012
- Completion date
- December 31, 2021
- Enrollment
- 120 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar depression